ZHBIO(SZ:300653) Zheng Quan Ri Bao Zhi Sheng·2025-11-18 11:05Core Viewpoint - The company has successfully maintained a complete bidding record in all previous centralized procurement projects for its meningitis products, which are currently being procured in 24 provinces, autonomous regions, and corps as of now [1]. Group 1: Market Position and Competitive Advantage - The company is positioned at the forefront of the industry in terms of market image, channel completeness, and brand loyalty [1]. - The company plans to actively respond to upcoming centralized procurement projects to further solidify its competitive advantage in the market [1]. Group 2: Regulatory Environment - As of now, there has been no issuance of relevant bidding documents following the notification from Tianjin City regarding the centralized maintenance of information for medical consumables related to hard brain (spinal) membrane patches, which is set to begin in June 2024 [1].